Henry Chen is the Founder and Managing Partner of Delos Capital. See contact routes.
Henry Chen is the Founder and Managing Partner of Delos Capital, a Hong Kong-based life sciences venture capital firm he established in 2014 after serving as a Partner at Permira and a Managing Director at Goldman Sachs. His investment thesis targets therapeutics and medical technology companies across the United States and Greater China, focusing on both venture-stage investments and active company creation through the firm’s in-house incubator, Delos Foundry. While specific check sizes and lead/follow behavior are not publicly detailed, the firm’s model blends conventional venture investing with incubation to build companies from the ground up. Notable portfolio companies include Curamir Therapeutics Inc. and Tulavi Therapeutics, both co-founded by Chen, as well as Tanvex BioPharma Inc., where he served as CEO and Chairman. Delos Capital distinguishes itself by resisting easy classification as a pure VC, instead operating as a cross-border life sciences firm that integrates company-building into its core strategy. Chen has not published public writing or a distinctive point of view beyond his firm’s operational model, which emphasizes the growing role of its inc
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Central.
Investors like Henry Chen · Full investor directory · Investor access · Company funding database